Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma

Therapeutic options for patients with multiple myeloma have multiplied in the past decade. However, multiple myeloma remains an incurable disease, and relapsed/refractory myeloma is characterized by genetic and cytogenetic alterations that drive resistance and result in progressively shorter duratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Cesar, Catamero, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184840/
https://www.ncbi.nlm.nih.gov/pubmed/37197721
http://dx.doi.org/10.6004/jadpro.2023.14.3.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184840/
https://www.ncbi.nlm.nih.gov/pubmed/37197721
http://dx.doi.org/10.6004/jadpro.2023.14.3.14

Ejemplares similares